GI Innovation Announces First Clinical Supply Agreement to Explore Combination Therapy for Prostate Cancer
SEOUL, South Korea, March 19, 2026 /PRNewswire/ -- GI Innovation announced on 19th that it has entered into a clinical supply agreement with Johnson & Johnson to evaluate a combination therapy in patients with metastatic castration-resistant prostate cancer (mCRPC) in...
GI
gi innovation
via Decaturdailydemocrat
Updated 1h ago

Source Verification
Corroboration Score: 1This story was independently reported by 1 sources. Click any source to read the original article.
Comments
0 commentsBe respectful and constructive.
Loading comments...
Previous
17-year-old advocate shares her NMOSD story to raise awareness
Next
UNC's Season Comes To An End, Tar Heels Fall In Overtime To VCU, 82-78
Related Articles
HealthEledon Pharma FY25 Net Loss Widens; Tegoprubart Phase 3 Development On Track In Kidney Transplant
Unknown-5h ago-1 sources
HealthOil Prices Edge Higher After Drone Attack Targeting Kuwait Oil Refinery
Unknown-5h ago-2 sources
HealthTUHU Car Inc. Reveals Fall In Full Year Profit
Unknown-5h ago-1 sources